Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
February 2, 2026
Approximately 5 minutes
Regulation of In Vitro Diagnostic Medical Devices in Portugal
Regulation of In Vitro Diagnostic Medical Devices in Portugal
1. Overview
INFARMED, I.P., the Portuguese National Authority for Medicines and Health Products, oversees the regulation of in vitro diagnostic medical devices (IVDDs) to ensure their safety, performance, and compliance with European standards. The framework is established by Decree-Law no. 189/2000 of 12 August, which transposes Directive 98/79/EC into national law. Source: https://www.infarmed.pt/web/infarmed-en/medical-devices/in-vitro-diagnostic-medical-devices-ivdds-and-applicable-legislation
2. Definition of IVDDs
An IVDD is any reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment, or system—used alone or in combination—intended by the manufacturer for in vitro examination of human-derived samples. It provides information on physiological or pathological states, congenital anomalies, safety and compatibility for recipients, or therapeutic monitoring. Sample containers designed for preservation are also considered IVDDs. Source: https://www.infarmed.pt/web/infarmed-en/medical-devices/in-vitro-diagnostic-medical-devices-ivdds-and-applicable-legislation
3. Applicable Legislation
The primary legislation is Decree-Law no. 189/2000, incorporating Directive 98/79/EC. Additional regulations include Decree-Law no. 145/2009 for activities under Article 36. References to annexes outline essential requirements, conformity assessments, and specific provisions for self-diagnosis and high-risk devices. Source: https://www.infarmed.pt/web/infarmed-en/medical-devices/in-vitro-diagnostic-medical-devices-ivdds-and-applicable-legislation
4. Responsibilities of Economic Operators
Manufacturer
The manufacturer is responsible for design, manufacture, packaging, and labelling before market placement. They request conformity evaluations, declare conformity, and ensure quality, safety, and performance through distributor training. Non-Portuguese manufacturers notify INFARMED for Annex II or self-diagnosis IVDDs using specific forms, providing certificates, Portuguese instructions, and declarations. Source: https://www.infarmed.pt/web/infarmed-en/medical-devices/in-vitro-diagnostic-medical-devices-ivdds-and-applicable-legislation
Distributor
Portuguese distributors ensure Portuguese labelling and instructions comply with essential requirements. They register IVDDs online per Article 12 and adhere to Decree-Law no. 145/2009. Translations require manufacturer authorization. Source: https://www.infarmed.pt/web/infarmed-en/medical-devices/in-vitro-diagnostic-medical-devices-ivdds-and-applicable-legislation
Importer
For customs clearance of potential IVDDs like reagents, importers obtain a declaration from INFARMED's Health Products Directorate, providing user statements, labelling, and manufacturer documentation. Source: https://www.infarmed.pt/web/infarmed-en/medical-devices/in-vitro-diagnostic-medical-devices-ivdds-and-applicable-legislation
5. CE Marking
The CE marking guarantees conformity with essential requirements and is mandatory for market placement. It must be affixed visibly and indelibly by the manufacturer. A four-digit code indicates Notified Body involvement for certain devices. Source: https://www.infarmed.pt/web/infarmed-en/medical-devices/in-vitro-diagnostic-medical-devices-ivdds-and-applicable-legislation
6. Conformity Assessment Procedures
Low-risk IVDDs undergo internal quality control under manufacturer responsibility (Annex III). High-risk (Annex II) and self-diagnosis devices require Notified Body involvement. Manufacturers in Portugal follow steps for CE marking and notify INFARMED for registration. Source: https://www.infarmed.pt/web/infarmed-en/medical-devices/in-vitro-diagnostic-medical-devices-ivdds-and-applicable-legislation
7. Notified Body
Notified Bodies, appointed by national authorities and recognized by the European Commission, conduct evaluations, authorize CE marking, issue certificates, ensure quality compliance, and cooperate with authorities. Source: https://www.infarmed.pt/web/infarmed-en/medical-devices/in-vitro-diagnostic-medical-devices-ivdds-and-applicable-legislation
8. Market Surveillance and Authority Functions
INFARMED ensures Directive implementation, compliance, and safety. Functions include rulemaking, EU participation, dispute resolution, clinical research assessment, record-keeping, market surveillance, and database contributions. Source: https://www.infarmed.pt/web/infarmed-en/medical-devices/in-vitro-diagnostic-medical-devices-ivdds-and-applicable-legislation
9. Important Notes
This framework emphasizes safety for patients and users, with strict requirements for high-risk IVDDs. For detailed procedures, refer to the annexes and specific guidelines. Source: https://www.infarmed.pt/web/infarmed-en/medical-devices/in-vitro-diagnostic-medical-devices-ivdds-and-applicable-legislation
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Frequently Asked Questions on Medical Devices in Portugal
INFARMED's FAQs address key aspects of medical devices in Portugal, including definitions, classifications, responsibilities, CE marking, conformity assessments, and market surveillance under Law-Decree nº 145/2009.
Approximately 5 minutes
Medical Device Vigilance System in Portugal
INFARMED oversees Portugal's medical device vigilance system, involving systematic incident reporting, investigation, and corrective actions by manufacturers, distributors, and users to protect public health under relevant decrees.